HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Sudhakar Bangera, Speaker at Vaccines Conferences
Keynote Presentation
Sudhakar Bangera, MBBS, MD, MMedSc, Fellow-Vaccinology Managing Partner AILEEN Clinical Research Services AILEEN, India

Biological therapeutics, also referred to as Biologicals, are those diverse group of medicines that are grown and then purified from large-scale cell cultures of bacteria or yeast, or plant or animal cells. Biologicals include a wide range of products such as vaccines, allergenic [....] » Read More

Rosane Cuber Guimaraes, Speaker at Vaccines Conferences
Keynote Presentation
Rosane Cuber Guimaraes, Bio-Manguinhos/ Fiocruz, Brazil

Since the beginning of Sars-CoV-2 virus pandemic in Brazil on March 2020, Fiocruz has been part of various national and international fronts for the search and production of a vaccine against COVID-19. With a long history and a tradition of more than 70 years in vaccines producti [....] » Read More

Angelo Tunin Chica Pergo, Speaker at Therapeutic Vaccines Conferences
Oral Presentation
Angelo Tunin Chica Pergo, Faculty Of Medicine Of Itajuba, Brazil

This is a psychometric study aimed at developing and validating a specific scale that assesses the vaccinal hesitancy (VH) behaviours of COVID-19 vaccines. Vaccine Hesitancy Scale for Covid-19 vaccines was developed in Brazil based on the Vaccine Hesitancy Scale (VHS), developed [....] » Read More

Hemanta Kumar Kar, Speaker at Vaccine Conference
Oral Presentation
Hemanta Kumar Kar, Kalinga Institute of Medical Sciences(KIMS), KIIT deemed to be University, India

WHO targeted the following global leprosy control achievements by 2030: 120 countries with zero new autochthonous cases, 70% reduction in annual number of new cases detected, 90% reduction in rate per million population of new cases with grade-2 disability (G2D) and 90% reducti [....] » Read More

Vasiliki Georgakopoulou, Speaker at International Vaccines conferences
Oral Presentation
Vasiliki Georgakopoulou, Medical School of National and Kapodistrian University of Athens, Greece

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a significant global issue that has major implications for the healthcare system. Mortality rates of SARS-CoV-2 infection vary by geographic region and are associated with age, comorbidities, and vacci [....] » Read More

Kaleem Ullah, Speaker at Vaccines Conferences
Oral Presentation
Kaleem Ullah, Unicef, Pakistan

Vaccine hesitancy: we do have a lot of issues from the community which make them hesitant towards vaccination process, includes disinformation about the vaccination spread by the community instigators play important role in this regards apart from that we do have a lot of religio [....] » Read More

Vasiliki Georgakopoulou, Speaker at International Vaccines conferences
Oral Presentation
Vasiliki Georgakopoulou, Medical School of National and Kapodistrian University of Athens, Greece

The Coronavirus Disease 2019 (COVID-19) has posed a severe worldwide public health threat, affecting multiple organs' function in addition to respiratory function. Several strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been circulatin [....] » Read More

Huixing Lin, Speaker at Vaccines Conferences
Oral Presentation
Huixing Lin, Nanjing Agricultural University, China

African swine fever (ASF) is caused by African swine fever virus (ASFV). The mortality rate of domestic pigs and wild boars is as high as 100%, and they can also infect pigs and ticks as carriers and infection hosts. So far there is no commercialized ASF vaccine. The prevention a [....] » Read More

Solange Whegang Youdom, Speaker at Immunology Conferences
Oral Presentation
Solange Whegang Youdom, University of Dschang, Cameroon

Data from the 2018 Demographic and Health Survey (DHS) was analyzed for children with at least one vaccination date in the home-based record (HBR). Immunization performance such as accessibility, drop-out, and timeliness, were assessed. Service quality was assessed using MOV. Mul [....] » Read More

Amarjeet Gambhir, Speaker at Vaccine Development Congress
Oral Presentation
Amarjeet Gambhir, Lady Hardinge Medical College & Associated Hospitals, India

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory system coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China and has been sweeping across the globe. It has been associated with a wide range of opportunistic bacterial and fungal infec [....] » Read More

Satyabrata Dandapat, Speaker at Vaccine Research Events
Oral Presentation
Satyabrata Dandapat, ICAR-Indian Veterinary Research Institute, India

Duck farming occupies an important position next to chicken farming in the Asian continent. Among various diseases affecting the duck populations, duck plague (DP) or duck viral enteritis, caused by Anatid herpesvirus-1, is the most significant contagious viral disease reported w [....] » Read More

Yusuf Ziya Sener, Speaker at Vaccine Development Congress
Oral Presentation
Yusuf Ziya Sener, Beypazarı State Hospital, Turkey

Infections, especially respiratory tract infections have unfavorable outcomes on cardiovascular system. It is well known that infections causes exacerbation of heart failure and triggering rupture of vulnerable plaques resulting in acute coronary syndromes. Therefore Influenza, p [....] » Read More

Deborah Hilton, Speaker at Vaccines Conferences
Oral Presentation
Deborah Hilton, Deborah Hilton Statistics Online, Australia

Background. The research rationale is that many economic, policy, and government implications result from the COVID-19 pandemic. Hilton published a literature review on COVID-19 research specific to Australia including policy and media releases. This Australian scientific litera [....] » Read More

Alex Zhu, Speaker at Vaccine safety congress
Poster Presentation
Alex Zhu, University of Duisburg-Essen, United States

Recently approved vaccines have shown remarkable efficacy in limiting SARS-CoV-2-associated disease. However, with the variety of vaccines, immunization strategies, and waning antibody titers, defining the correlates of immunity across a spectrum of antibody titers is urgently re [....] » Read More

Sherif Salah , Speaker at Vaccines Conferences
Poster Presentation
Sherif Salah , Cairo University, Egypt

A novel mode of action for HIV assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protections against destructors by the cytotoxic CD8+ T-cells. Depends on this novel postulation a new formulation treatment terme [....] » Read More

Zahra Mohammed A Alhajjaj , Speaker at Vaccines Conferences
Poster Presentation
Zahra Mohammed A Alhajjaj , Collage of Medicine, Hail University, Saudi Arabia

Introduction: Coronavirus (COVID-19) a new member of the human coronavirus’s family, was identified in 2019 as the causative agent of a new disease outbreak in China associated with severe medical complications and even death in some cases. The unavailability of a vaccine o [....] » Read More

Jamil M A S Obaid , Speaker at Vaccine Research Events
Poster Presentation
Jamil M A S Obaid , Ibb University, Yemen

Urinary tract infections (UTIs) are one of the most common bacterial infections with global expansion particularly in Egypt. These infections are predominantly caused by uropathogenic Escherichia coli (UPEC). In a trial to prevent these infection we proposed this study in which m [....] » Read More

Vincenzo Alfano, Speaker at Vaccines Conferences
Keynote Presentation
Vincenzo Alfano, University of Messina, Italy

Attitude toward vaccination is doubtless an important determinant of public health, and this become evident during a pandemic. The issue, periodically debated within European societies since some years, especially with respect to occasional surge of diseases in given years and se [....] » Read More

Mayra Ramos Suzarte, Speaker at Therapeutic Vaccines Conference
Keynote Presentation
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba

Since the first case of COVID 19 was reported in China in 2019, the world has turned to seek therapeutic alternatives for the treatment of this disease and search vaccines against it. About 300 million people in the world have been affected by the pandemic without recognizing age [....] » Read More

Christine Bricault, Speaker at Vaccines Conferences
Oral Presentation
Christine Bricault, Sanofi Vaccines, United States

Human metapneumovirus (hMPV) is a major cause of acute respiratory tract infections in both infants and older adults. Currently there are no approved vaccines or antibody therapies for treatment against infection from hMPV. The key target of neutralizing antibodies is the viral f [....] » Read More

Julia Bespyatykh, Speaker at Vaccine Conferences
Oral Presentation
Julia Bespyatykh, Federal Research and Clinical Centre of Physical-Chemical Medicine, Russian Federation

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread extremely quickly around the world, leading to medical and economic crises. Vaccination against SARS-CoV-2 infection is considered an effective preventive measu [....] » Read More

Mohammad Owais, Speaker at Immunology Conferences
Oral Presentation
Mohammad Owais, Aligarh Muslim University, India

The scourge of tuberculosis is continuing to toll around 1.5 million human lives annually. The only vaccine against tuberculosis is BCG which gives varied protection in various regions and races of the world. Developing new vaccine based on mycobacterial strains is a challenging [....] » Read More

Tibyan A  Abdallah, Speaker at Vaccines Conferences
Oral Presentation
Tibyan A Abdallah, University of Khartoum, Sudan

Background: To combat the newly emerging pandemic (Corona virus disease 2019 (COVID-19)) different preventive measures are advised. World Health Organization recommended vaccination as an important intervention for ending this pandemic. This study aims to understand the willingne [....] » Read More

Mohammad Jalil Zorriehzahra, Speaker at Speaker for Vaccine Conferences- Mohammad Jalil Zorriehzahra
Oral Presentation
Mohammad Jalil Zorriehzahra, Iranian Fisheries Science Research Institute, Greenland

Aquaculture currently has the highest growth in the world among different disciplines for the production of protein materials (15.7%). However, the occurrence of various infectious diseases (bacterial, viral, fungal and parasitic) among aquatic animals are a serious risk in this [....] » Read More

Nemat Khansari, Speaker at Vaccines Conferences
Oral Presentation
Nemat Khansari, Tehran University Medical Sciences, Iran (Islamic Republic of)

After the discovery of cowpox inoculation that can protect human from getting smallpox infection, vaccination became an important protective means for prevention measures for various infectious diseases. Although, vaccination was first applied to reduce mortality and morbidity fr [....] » Read More

Laleh Yazdanpanah Goharrizi, Speaker at Therapeutic Vaccines Conferences
Oral Presentation
Laleh Yazdanpanah Goharrizi, Agricultural Research Education and Extension Organization, Iran (Islamic Republic of)

Researchers are looking for pathogens of shrimp without pathogens or SPF and shrimp tolerant to viral agents that are not pathogenic to humans and can only be pathogenic to shrimp and crustaceans. In 1998, a scientist stated that shrimp and insects could retain viruses for long p [....] » Read More

Muhammad Naveed Anwar, Speaker at Speaker for Vaccine Conferences- Muhammad Naveed Anwar
Oral Presentation
Muhammad Naveed Anwar, Chinese Academy of Agricultural Sciences, Pakistan

Japanese encephalitis (JE) is a vector-borne zoonotic viral disease caused by (Japanese encephalitis virus, JEV). Vaccination is the most effective way to control JE in both humans and animals. However, JEV genotype shift that the dominant genotype III (GIII) has been replaced by [....] » Read More

Mina Ziarati, Speaker at COVID- 19 Vaccine Conferences
Oral Presentation
Mina Ziarati, Islamic Azad University, Iran (Islamic Republic of)

In contemporary world, Coronavirus disease (COVID-19) is concerned as a transmittable disease from bat to humans and a factor caused public health anxiety. Although, several measures were performed to treat it but still the mortality is seen in around the world. One of the most s [....] » Read More

Seyedeh Sajedeh Mousavi, Speaker at Bacterial Infection Conferences
Oral Presentation
Seyedeh Sajedeh Mousavi, Islamic Azad University, Iran (Islamic Republic of)

COVID-19 is a pandemic of unprecedented proportions in recent human history. There have been around 200 million confirmed cases and four million fatalities worldwide in less than 18 months since the pandemic began. Additionally, a great deal of work has gone into finding vaccines [....] » Read More

Maduike Ezeibe, Speaker at Vaccine Congress
Oral Presentation
Maduike Ezeibe, Michael Okpara University of Agriculture, Nigeria

Full-protection from COVID-19 vaccines lasts only three months. So, COVID-vaccination should be bi-monthly. Failure to revaccinate duly leads to antibody levels, lower than titer that prevents infections. When viruses experience vaccine-antibodies and still establish infections, [....] » Read More

Emmanuel Ifeanyi Obeagu, Speaker at Vaccines Conferences
Oral Presentation
Emmanuel Ifeanyi Obeagu, Kampala International University, Uganda

Immunization remains one of the cheapest and most cost effective means of protecting the masses from vaccine preventable diseases. Factors affecting Childhood immunization uptake at general practice level may be considered in terms of sociodemographic variables, attitude and prac [....] » Read More

Nivedita Gupta, Speaker at Immunology Conferences
Oral Presentation
Nivedita Gupta, Shri Chitragupta Post Graduate College, India

This paper deals with mathematical modelling and analysis of a SEIQR model to study the dynamics of COVID-19 considering delay in conversion of exposed population to the infected population. The model is analyzed for local and global stability using Lyapunov method of stability f [....] » Read More

Sawsan Abuhammad, Speaker at Immunology Conferences
Oral Presentation
Sawsan Abuhammad, Jordan University of Science and Technology, Jordan

Objectives It is important to acknowledge the factors that impact vaccine acceptance among different population groups, especially among pregnant and lactating mothers. Pregnant and lactating mothers play a significant role in deciding if their child/fetus will be vaccinated. Ho [....] » Read More

Yusuke Oji, Speaker at Endocrinology Conferences
Oral Presentation
Yusuke Oji, Osaka University Graduate School of Medicine, Japan

The WT1 gene is an oncogene overexpressed in leukemia and various types of solid cancers. WT1 gene product is highly immunogenic and a promising target for cancer immunotherapy. We have developed a WT1 peptide-based therapeutic cancer vaccine and shown its clinical pote [....] » Read More

Joseph Anejo Okopi, Speaker at Endocrinology Events
Oral Presentation
Joseph Anejo Okopi, Federal University of Health Sciences Otukpo, Nigeria

Lassa fever (LF) is a zoonotic disease associated with an acute and potentially fatal hemorrhagic illness caused by the Lassa virus (LASV), a member of the family Arenaviridae, Genus Arenavirus. It was discovered in 1968 when two missionary nurses died in Nigeria. The virus is na [....] » Read More

Sissy Therese Sonnleitner, Speaker at Vaccine Research Events
Oral Presentation
Sissy Therese Sonnleitner, Innsbruck Medical University, Austria

Different scenarios explaining the emergence of novel variants of concern (VOC) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported, including their evolution in scarcely monitored populations, in animals as alternative hosts, or in immunocompro [....] » Read More

Mohammad Zoladl, Speaker at Endocrinology Events
Oral Presentation
Mohammad Zoladl, Yasuj University of Medical Sciences, Iran (Islamic Republic of)

Since previous centuries to now, the occurrence of pandemics has been as complex health problem in the world. Production and administration of vaccination has been an important role in the management and control of these pandemics. The main point of this success is participation [....] » Read More